Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...

NVIDIA (NVDA) and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab ...

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

Eli Lilly and Nvidia will launch a co-innovation AI lab to accelerate drug discovery. The companies will jointly invest up to $1 billion over five years to support the lab, which is based in the Bay ...

Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector. Nvidia (NVDA) and Eli Lilly (LLY) said they're investing up to $1B over five years to develop ...

On the surface, the two companies don't seem as if they'd have much in common. Both benefit from advancing medical technology using AI, however. 10 stocks we like better than Nvidia › In a corporate ...

Eli Lilly and Co. and Purdue Strategic Ventures recently participated in a $12 million funding round to support a new remote lab platform aimed at significantly decreasing the time it takes to ...

Nvidia and Eli Lilly are partnering to launch a co-innovation lab to use Nvidia's artificial-intelligence and robotics expertise for drug discovery. The companies said Monday they would invest up to ...